KLF5介导的CDCA5表达促进瘤的发展和卵巢上皮癌的进展
Xiaohong Chen1, Meiying Zhou2, Shouye Ma2
1The First Clinical Medical College, Lanzhou University, Lanzhou, 730030, China; Department of Gynecology, Gansu Provincial Hospital, Lanzhou, 730000, China.
Experimental cell research
|May 29, 2023
概括
细胞分裂周期相关5 (CDCA5) 通过激活细胞周期和抑制P53通路,促进上皮卵巢癌 (EOC) 的进展. 向CDCA5可能为EOC治疗提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
背景情况:
- 与细胞分裂周期相关的5 (CDCA5) 与各种癌症有关.
- 它在上皮卵巢癌 (EOC) 进展中的特定作用仍然在很大程度上未被阐明.
- 了解CDCA5在EOC中的功能对于开发向疗法至关重要.
研究的目的:
- 为了研究CDCA5在EOC中的临床意义.
- 阐明CDCA5在EOC进展中的生物学功能和潜在的分子机制.
- 探索CDCA5作为EOC治疗点的潜力.
主要方法:
- 在EOC组织中分析CDCA5mRNA和蛋白质表达.
- 在体外研究涉及CDCA5敲击和EOC细胞系的过度表达.
- 在体内外移植的瘤模型来评估CDCA5对瘤生长的影响.
- 调查KLF5和CDCA5.5之间的监管关系.
主要成果:
- CDCA5在EOC中显著上调,与不良的临床病理特征和不良预后相关.
- CDCA5促进了EOC细胞的增殖,入侵和转移,同时抑制了亡.
- 通过调节细胞周期和P53通路,CDCA5破坏了线粒体介导的亡.
- KLF5直接与CDCA5促进体结合,增强其表达并促进EOC细胞的增殖.
结论:
- CDCA5在通过KLF5/CDCA5/细胞循环和P53信号轴促进EOC进展方面发挥着关键作用.
- CDCA5上调与积极的EOC表型和不良结果有关.
- 针对KLF5/CDCA5通路为EOC提供了一个潜在的治疗策略.
相关概念视频
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...